Andrew J. Schwab

Director

Andrew J. Schwab (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in CAMP4 THERAPEUTICS CORPORATION (CAMP). The largest single filing was $1.6M of CAMP (400,000 sh × $4.04, as filed), executed Aug 27.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.5M

shares × price, as filed

Last traded

Aug 27

Filed Aug 31

Median ADV $1.1M across their filed names

Open performance→

Volume by month

Buys $10.0M Sells $4.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

CAMP

CAMP4 THERAPEUTICS CORPORATION CAMP · 1 buy · 2 sells 3 filings SKYE SKYE SKYE · 0 buys · 1 sell 1 filing TRDA

Entrada Therapeutics, Inc. TRDA · 0 buys · 1 sell 1 filing

Recent filings

CAMPSALE CAMP4 THERAPEUTICS CORPORATION View filing → $1.6M
400,000 sh × $4.04
Exec Aug 27
Filed Aug 31 · 5:05 PM ET CAMPSALE CAMP4 THERAPEUTICS CORPORATION View filing → $880K
191,865 sh across 3 lots
Exec Aug 19
Filed Aug 21 · 4:59 PM ET SKYESALE Skye Bioscience, Inc. View filing → $770K
222,621 sh across 2 lots
Exec Aug 21 2025
Filed Aug 22 2025 · 5:30 PM ET TRDASALE Entrada Therapeutics, Inc. View filing → $777K
112,156 sh across 4 lots
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET CAMPPURCHASE CAMP4 THERAPEUTICS CORPORATION View filing → $10.0M
909,090 sh × $11.00
Exec Oct 15 2024
Filed Oct 15 2024 · 5:30 PM ET SKYESALE Skye Bioscience, Inc. View filing → –
251,060 sh across 2 lots · price not plausible
Exec Sep 11 2024
Filed Sep 13 2024 · 5:30 PM ET